GSK3B and colorectal carcinoma: NAT10 promotes CRC progression through the NAT10/kinesin family member 2A (KIF23)/glycogen synthase kinase 3 beta (GSK‐3β)/β‐catenin axis, and its expression is mediated by GSK‐3β in the feedback loop.75